Oxigene (OXGN) 0.90 -0.0003

Oxigene, Inc.
(OXGN) 0.90 -0.0003

Last Trade:	0.90	Day Range:	0.881 - 0.94
Trade Time:	08:05PM	52wk Range:	0.82 - 5.36
Prev. Close:	0.9003	Market Cap:	14.55M
Open:	0.90	Div Yield:
Volume:	66851	PE:
EPS:	-0.81

The Latest On OXGN

OXiGENE Reports FY2011 Results, Management Change 3/13/12 4:29pm

Small Biotechnology Stocks Roar, Profit Now 1/26/12 3:03pm

Microcap Movers for Monday December 12, 2011 12/12/11 6:43pm

Morning Market Movers 12/12/11 11:05am

OXiGENE and Azanta A/S Establish Partnership to Provide ZYBRESTAT for ATC in Europe on Named Patient, Compassionate Use Basis 12/12/11 9:05am

OXiGENE Presents Data From FAVOR Study of ZYBRESTAT in PCV 12/7/11 9:01am

OXiGENE Announces Purchase Agreement for Up to $20 Million With Lincoln Park Capital 11/28/11 9:31am

OXiGENE Reports Final Data From Phase 2 FALCON Study of ZYBRESTAT in Non-Small Cell Lung Cancer 11/3/11 4:32pm

OXiGENE Presents Data Confirming Survival Benefit of ZYBRESTAT in Patients With Anaplastic Thyroid Cancer 9/14/11 1:17pm

OXiGENE Trades to Daily High, Near Breakout Level 9/13/11 2:14pm

OXiGENE Announces Changes to Board of Directors 9/9/11 4:00pm

OXiGENE Announces Restructuring to Focus Resources on Promising Earlier Stage Clinical Programs 9/1/11 8:01am

OXiGENE Reports FY2011 Results, Management Change 3/13/12

Small Biotechnology Stocks Roar, Profit Now 1/26/12

Microcap Movers for Monday December 12, 2011 12/12/11

Morning Market Movers 12/12/11

OXiGENE and Azanta A/S Establish Partnership to Provide ZYBRESTAT for ATC in Europe on Named Patient, Compassionate Use Basis 12/12/11

OXiGENE Presents Data From FAVOR Study of ZYBRESTAT in PCV 12/7/11

OXiGENE Announces Purchase Agreement for Up to $20 Million With Lincoln Park Capital 11/28/11

OXiGENE Reports Final Data From Phase 2 FALCON Study of ZYBRESTAT in Non-Small Cell Lung Cancer 11/3/11

OXiGENE Presents Data Confirming Survival Benefit of ZYBRESTAT in Patients With Anaplastic Thyroid Cancer 9/14/11

OXiGENE Trades to Daily High, Near Breakout Level 9/13/11

OXiGENE Announces Changes to Board of Directors 9/9/11

OXiGENE Announces Restructuring to Focus Resources on Promising Earlier Stage Clinical Programs 9/1/11

Microcap Movers for Monday December 12, 2011 12/12/11

OXiGENE Trades to Daily High, Near Breakout Level 9/13/11

Biotech/Pharma Stocks Trading News Alert: Aethlon Medical, OXiGENE, Adventrix, Chelsea Therapeutics, Exelixis 8/10/11

Major Pops In Large And Small Cap Stocks 8/9/11

Stock Market Movers And Key Small Cap Alert 7/13/11

Top Percentage Gainers and Losers as of 2pm 7/5/11 7/5/11

Top Percentage Gainers and Losers as of 12pm 6/29/11 6/29/11

Top Percentage Gainers and Losers as of 2pm 06/07/11 6/7/11

Top Percentage Gainers and Losers as of 12pm 06/07/11 6/7/11

Top Percentage Gainers and Losers as of 2:15pm 5/16/2011 (VITA, SYK, CISG, TISA, ENOC, TSTC, SPMD, KNDI, ABIO, KONG, OXGN, VRML, PSTR, FXCM, ATRN, SYMX, GSL) 5/16/11

Top Percentage Gainers and Losers as of 12:15pm 5/16/2011 (VITA, TISA, CISG, ENOC, SPMD, ABIO, BRP, KONG, AERL, SYK, WIFI, GSL, OXGN, ATRN) 5/16/11

Top Percentage Gainers and Losers as of 2pm 5/12/11 (DSCO, OXGN, QCOR, QTWW, SNSS, RPTP, VICL, ORBK, PNSN, SPMD, CLWR, DEXO, CCIH, TNGN, NQ, SYMX, BAC, INTC) 5/12/11

Trade OXGN
NOW!

Partner Headlines

OXiGENE Inc. Reports Operating Results (10-Q) 5/11/12

OXiGENE Inc. Reports Operating Results (10-K) 3/29/12

Shrugging Off the Selling: XOMA, GA, and OXGN Are Sending a Clear Message 3/6/12

Take the Hint. OXiGENE (OXGN), Keryx (KERX), & BroadVision (BVSN) in Focus 2/7/12

5 Breakout Stocks to Eye for a Buy 1/20/12

OXiGENE Inc. Reports Operating Results (10-Q) 11/10/11

ASCO: Thursday's Cancer Stock Winners, Losers 5/19/11

ASCO: Traders Love Speculative Cancer Stocks 5/19/11

Biotech Stock Mailbag: Celsion 5/13/11

OXiGene: Small-Cap Winners 5/12/11

TiVo: Small-Cap Winner 4/20/11

Press Releases

OXiGENE Reports First Quarter 2012 Financial Results 5/9/12 GlobeNewswire

OXiGENE Announces First Quarter 2012 Earnings Conference Call and Webcast 5/2/12 GlobeNewswire

OXiGENE Reports Data Showing Median Survival and One-Year Survival Improvement in Anaplastic Thyroid Cancer Patients Treated With ZYBRESTAT(R) and Chemotherapy 4/30/12 GlobeNewswire

OXiGENE and Azanta A/S Establish Partnership 4/22/12 Emailwire

OXiGENE Announces Full Year 2011 Earnings Conference Call and Webcast 3/6/12 GlobeNewswire

EGOH, BMTI, FORC and OXGN are the Daily Market Movers for February 7th from OTCPicks.com 2/7/12 Emailwire

OXiGENE to Present at BIO CEO & Investor Conference 2/6/12 GlobeNewswire

Small-Cap Stock Trade Review: OXiGENE Report Featured on MicroStockProfit.com 12/13/11 GlobeNewswire

OXiGENE and Azanta A/S Establish Partnership to Provide ZYBRESTAT(TM) for ATC in Europe on Named Patient, Compassionate Use Basis 12/12/11 GlobeNewswire

OXGN, AMWI, ORRV and AFFY are the Daily Market Movers for December 12th from OTCPicks.com 12/12/11 Emailwire

OXiGENE Presents Data From FAVOR Study of ZYBRESTAT in PCV 12/7/11 GlobeNewswire

Get the latest OXGN stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Oxigene, Inc. stock price.

Oxigene, Inc. by YCharts

Oxigene (OXGN) 0.90 -0.0003

Quotes

Analysis

Twitter

Ownership

Earnings

The Latest On OXGN

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Latest from Premium

Brain Trust

Popular Channels

Tools & Features

About Benzinga

Social